51759-505-13 : NDC 2026 Code

51759-505-13 : Ustekinumab-aekn ( Selarsdi )

Additionally :

You can get information about “51759-505-13” NDC code in 51759-505-13 in HTML format

HTML | 51759-505-13 in TXT (Plain Text) format

TXT | 51759-505-13 in PDF (Portable Document Format)

PDF | 51759-505-13 in XML format

XML formats.

NDC Code : 51759-505-13 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51759-505-13",
    "PackageDescription": "1 VIAL in 1 CARTON (51759-505-13)  / .5 mL in 1 VIAL",
    "NDC11Code": "51759-0505-13",
    "ProductNDC": "51759-505",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Selarsdi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ustekinumab-aekn",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20250312",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761343",
    "LabelerName": "Teva Pharmaceuticals USA, Inc.",
    "SubstanceName": "USTEKINUMAB-AEKN",
    "StrengthNumber": "45",
    "StrengthUnit": "mg/.5mL",
    "Pharm_Classes": "Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251016",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}